SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-025175
Filing Date
2024-08-07
Accepted
2024-08-07 16:05:39
Documents
16
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20240806_8k.htm   iXBRL 8-K 29073
2 EXHIBIT 99.1 ex_709669.htm EX-99.1 94831
7 geovax.jpg GRAPHIC 5295
  Complete submission text file 0001437749-24-025175.txt   292307

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA govx-20240806.xsd EX-101.SCH 3890
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20240806_def.xml EX-101.DEF 13442
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20240806_lab.xml EX-101.LAB 17669
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20240806_pre.xml EX-101.PRE 13419
18 EXTRACTED XBRL INSTANCE DOCUMENT govx20240806_8k_htm.xml XML 4782
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

IRS No.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 241183580
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)